Interestingly, genetic suppression of transgenic APP in a human APP mouse model of AD [tetracycline-responsive APP-transgenic mice (APP/TTA, where TTA stands for tetracycline-controlled transactivator protein)] was shown to rescue hypersynchronous network activity (Born et al., 2014). The gene discussed is APP; the disease is Alzheimer disease.